Zoetis appoints US Diagnostics executive director and chief medical officerJanuary 10, 2018Zoetis has appointed Richard E. Goldstein, DVM, DACVIM, DECVIM-CA to the position of executive director and chief medical officer, US Diagnostics, effective Feb. 5. Dr. Goldstein will lead the diagnostics team in expanding its product portfolio and will spearhead the division's studies and publishing opportunities. "Dr. Goldstein is a well-respected, internationally-renowned veterinarian in small animal internal medicine and we're honored to have him join our Zoetis team," said Lisa Lee, vice president, US Diagnostics and Business Solutions, Zoetis. "His award-winning work, research, and passion for preventing genetic and infectious diseases make him an ideal fit for our company as we continue to develop innovative technologies and solutions to diagnose disease as well as treat and improve the lives of pets." In his role at Zoetis, Goldstein will work closely with the US Companion Animal Division to develop educational events for sales and marketing, while leading the company's "Predict, Prevent, Detect and Treat" strategy. He also will manage the Key Opinion Leader program. Goldstein and his team will continue to emphasize digital innovation, diagnostics, genetic tests, and biodevices as important tools to help veterinarians make better healthcare decisions informed by data. Prior to joining Zoetis, Goldstein spent 12 …
SPONSORED CONTENTA Modern Approach to Parasite PreventionWith evolving parasite threats, traditional preventatives may not be enough. Discover how innovation is changing the landscape of protection. + Learn More
Henry Schein helps raise $10K for AAEP's 'Collegiate Challenge'January 4, 2018Henry Schein Animal Health, the U.S. animal health business of Henry Schein Inc., recently led a fundraising effort that raised $10,000 for the American Association of Equine Practitioners (AAEP) Foundation in support of its educational programming for the next generation of equine veterinary professionals. Jeannie Jeffery, national director of equine sales for Henry Schein Animal Health, presented the check to Richard Mitchell, DVM, AAEP Foundation chairman, at the 63ndĀ annual AAEP Convention held in San Antonio. Henry Schein joined supplier partners Zoetis, Neogen, and Rood & Riddle to support the AAEP Foundation's "Collegiate Challenge," an initiative that encouraged convention attendees to make donations that support the following AAEP programs: student chapter activity; courses in dentistry, podiatry, and horses handling; and continuing education programs. Henry Schein and its supplier partners matched convention attendee donations up to a total donation of $10,000. Combined with Henry Schein and its partners' donation, the AAEP Foundation raised more than $24,000 through the "Collegiate Challenge." "We extend a heartfelt thank you to all who donated during the convention to the 'Collegiate Challenge'," Dr. Mitchell said. "The incredible match made by our friends at Henry Schein, Zoetis, Neogen, and Rood & Riddle will allow our foundation to continue …
USDA grants Zoetis' Vanguard Rapid Resp one-year DOIDecember 19, 2017The USDA has granted Zoetis' Vanguard Rapid Resp intranasal vaccine line one-year duration of immunity (DOI) claims for Bordetella bronchiseptica, canine adenovirus type 2 (CAV-2), and canine parainfluenza virus (CPiV). Vanguard Rapid Resp is the first and only intranasal vaccine line in the US that has been demonstrated to provide one year of protection against three important canine infectious respiratory diseases (CIRD), according to the company. "The demonstration of a one-year duration of immunity for all three antigens in Vanguard Rapid Resp represents an important step in the protection of dogs from CIRD. This new DOI confirms the efficacy of a single product that provides both rapid and durable protection against these important antigens in the CIRD complex," said Stephan Carey, DVM, Ph.D., DACVIM, assistant professor of Small Animal Clinical Sciences at Michigan State University College of Veterinary Medicine, consultant for Zoetis. "This extended DOI is essential in reducing morbidity and mortality from infectious respiratory disease among dogs in social or commingled environments such as boarding facilities and shelters." Vanguard Rapid Resp is available in three antigenic combinations (Bb + CPiV + CAV-2; Bb + CPiV; Bb only), and all of these choices can be administered with a syringe …
What Veterinary Practice News readers loved in 2017December 15, 2017Another new year is upon us, but before we embrace 2018 and all it might have to offer veterinary professionals and the industry, let's recap Veterinary Practice News'Ā 10 most-read features of 2017. 1. Canine influenza virus 2017: Beyond two show dogs 2. 10 secrets to keep your veterinary nurses happy 3. University of Minnesota develops cancer drug that helps dogs with hemangiosarcoma 4. Study: Cats eating dry food have increased risk for developing Type 2 diabetes 5. Zoetis earns license for Cytopoint skin therapy 6. Raising greyhound health awareness 7. American Association of Feline Practitioners revises declawing position 8. The 7 top challenges facing veterinary medicine in 2017 9. Petco officially enters the veterinary hospital ring with Thrive 10. The strangest things vet techs have heard clients say
Zoetis launches Vanguard CIV H3N2/H3N8 vaccine for canine influenzaDecember 12, 2017Zoetis' Vanguard CIV H3N2/H3N8 is a new bivalent vaccine helps protect dogs against CIV H3N2 and CIV H3N8, which have caused serious disease outbreaks in 38 states across the US.1 In an efficacy study, dogs that received the Vanguard CIV H3N2/H3N8 vaccine were protected from disease after CIV H3N2 challenge.2,3,4 Vaccination also appeared to help decrease the number of days after challenge that dogs shed CIV H3N2 virusāfrom an average of 4.9 days in the placebo-vaccinated controls to an average of 1.3 days in Vanguard CIV H3N2/H3N8 vaccinates.2,5,6 During a safety study that involved 364 dogs, including 164 client-owned dogs and 200 dogs from commercial breeding facilities, 725 doses of vaccine were administered and no significant adverse events were observed.7 Dogs that frequently are in the company of others could benefit from the protection Vanguard CIV H3N2/H3N8 offers, said Stephan Carey, DVM, Ph.D., DACVIM, assistant professor, Small Animal Clinical Sciences at Michigan State University College of Veterinary Medicine, and past president of The Veterinary Comparative Respiratory Society, and Zoetis consultant. "Dogs that attend day care, visit the dog park, or stay at boarding facilities are all at risk for contracting either strain of CIV," he said. …
American Humane Hero Veterinarian, Veterinary Nurse 2018 nominations openDecember 8, 2017American Humane has announced that nominations are open for the fifth annual American Humane Hero Veterinarian and Hero Veterinary Nurse Awards, sponsored by Zoetis. For millions of Americans, animals are not just their best friends, but also their heroes. Whether they are lending eyes to the blind or ears to the deaf, protecting the sleeping family or the soldier, or providing a welcoming kiss at the end of a hard day, animals affect us in many ways. Behind almost every hero pet (and millions more animals) is a hero veterinarian or hero veterinary nurse or technician. These benefactors save and improve the lives of our two- and four-legged best friends in many ways, and for the past four years, American Humane's awards ceremony has honored their tremendous achievements. Pet owners and animal lovers alike are invited to visit herovetawards.org between now and Feb. 8 to nominate their favorite veterinary professionals. The awards are not limited to companion animal veterinarians. Professionals from all fields of veterinary medicine are eligible for entry including, but not limited to, those who work in research, emergency services, shelters, and those who work with large and exotic animals. The …
Zoetis accepting research grant proposals on controlling parasitic diseaseDecember 1, 2017ZoetisĀ is accepting grant proposals for research into innovative approaches to help protect dogs, cattle, sheep, and poultry from parasitic diseases and to extend the efficacy of therapeutics through new formulations. Through a grant awards program, Zoetis will award a minimum of $25,000 and maximum of $150,000 to support each selected grant proposal. More than one grant may be awarded. "We at Zoetis are interested in advancing novel approaches to protect animals from parasitic diseases, to improve the health and productivity of livestock animals and to help companion animals live longer, healthier lives," saidĀ Debra Woods, Ph.D., research director, head of Parasitology Global Therapeutics Research for Zoetis. "Through this grant program, we aim to energize investigation into anti-parasitic therapeutics research and advance science in this area of high need in animal health." The company seeks proposals focused on helping to protect dogs from heartworm diseaseĀ by taking novel biological or biopharmaceutical approaches to prevention and on developing diagnostic tools to detect the early stages of infection. Projects might also look at understanding early stages of heartworm infection, including the mechanisms of their migration through the tissues to the heart. In cattle and sheep, the company seeks proposals that explore …
Kansas State University expands joint DVM training program with ChinaNovember 3, 2017A program initiated by Kansas State University that helps students from China earn veterinary medical degrees in the U.S. is increasing the number of students it serves. A memorandum-of-understanding signing ceremony was conducted Oct. 19 in Beijing, China, expanding the U.S.-China Joint Doctor of Veterinary Medicine Scholarship Program, which was initiated in 2012 by the U.S.-China Center for Animal Health at Kansas State University, along with the China Agricultural University and Chinese Veterinary Medical Association. The joint program has been sponsored by China Scholarship Council, Kansas State University, Zoetis and the International Veterinary Collaboration for China. Zoetis originally provided funding to the program for 30 students' pre-veterinary tuition and related activities. The China Scholarship Council has provided full-ride scholarships for four years of DVM tuition and five years for living stipends. Kansas State University has sponsored the program by providing program management service and additional scholarships. Under the new agreement, Zoetis will continue to support the program by providing pre-veterinary tuition funding for an additional 15 students with Kansas State University and the Chinese Veterinary Medical Association. The U.S.-China Joint Doctor of Veterinary Medicine Program is a five-year training program with …
Zoetis launches Witness FFH test to detect three feline diseasesOctober 4, 2017Zoetis Inc. announced the launch of Witness FFH, a triple test that detects antigens to feline leukemia virus (FeLV) and feline heartworm, as well as antibodies to feline immunodeficiency virus (FIV). Witness FFH is a simple, convenient, and cost-effective test that requires no refrigeration and is priced comparably to current FeLV-FIV tests on the market with the added benefit of heartworm testing, the company stated. "Zoetis is committed to delivering high-quality, point-of-care diagnostics to help easily and affordably diagnose conditions or diseases that affect the quality or duration of a pet's life," said Chris Demiris, marketing director, U.S. Diagnostics at Zoetis. "The new Witness FFH test is a rapid, reliable test that helps keep cats healthy." "A shared clinical sign of all three diseases is vomiting, so a triple test helps veterinarians make accurate diagnoses more quickly," said Matthew Krecic, DVM, MS, MBA, DACVIM, senior technical services manager, U.S. Diagnostics at Zoetis. "Sick cats may also have FeLV or FIV; therefore, testing for those concurrent with heartworm is sensible." Veterinarians should consider testing for heartworm infection in cats because clinical signs can be confused with those of many other diseases, including feline asthma, …
Zoetis seeks to award scholarships for 2018-2019October 3, 2017Zoetis Inc. and the Association of American Veterinary Medical Colleges are partnering again to provide scholarships to second- and third-year veterinary students in the U.S. and the Caribbean. Recipients of the 2018 Zoetis Veterinary Student Scholarship Award will receive $2,000 for the upcoming 2018-2019 school year. Interested students can apply atĀ VETVANCE, a free online resource for veterinary students and recent graduates. The application period is from now through Nov. 30. Eligibility criteria Awards are given based on academic excellence, financial need, diversity, sustainability, leadership, and career interest. Scholarships will be awarded to students in all areas of professional interest, including food animal medicine, small animal clinical medicine, research, government services, public health, and organized veterinary medicine. The award is part of the Zoetis Commitment to Veterinarians, a platform the company created to support leadership and diversity among future veterinarians, and to help offset the significant costs associated with a veterinary education. Winners will be announced at the 2018 Student American Veterinary Medical Association Symposium. To date, Zoetis' program has awarded nearly $6 million in scholarships to more than 2,700 students. To learn more about …